A prospective study of bisphosphonate use and risk of colorectal cancer

Journal of Clinical Oncology

Volumn 30, Issue 26, 2012, Pages 3229-3233

  Khalili, Hamed ^a   Huang, Edward S ^a   Ogino, Shuji ^b   Fuchs, Charles S ^b,c   Chan, Andrew T ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID;

AGED; ARTICLE; CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; TREATMENT DURATION;

AGED; COLORECTAL NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; TIME FACTORS;

EID: 84866555641     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.2670     Document Type: Article

References (23)

1. Aapro M, Abrahamsson PA, Body JJ, et al: Guidance on the use of bisphosphonates in solid tumours: Recommendations of an international expert panel. Ann Oncol 19:420-432, 2008
2. Gnant M, Mlineritsch B, Schippinger W, et al: Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360:679-691, 2009
3. Wood J, Bonjean K, Ruetz S, et al: Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302:1055-1061, 2002 (Pubitemid 34920226)
4. Neville-Webbe HL, Holen I, Coleman RE: The anti-tumour activity of bisphosphonates. Cancer Treat Rev 28:305-319, 2002 (Pubitemid 36054539)
5. Green JR: Antitumor effects of bisphosphonates. Cancer 97:840-847, 2003 (suppl 3)
6. Rachner TD, Singh SK, Schoppet M, et al: Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. Cancer Lett 287:109-116, 2010
7. Chlebowski RT, Chen Z, Cauley JA, et al: Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol 28:3582-3590, 2010
8. Newcomb PA, Trentham-Dietz A, Hampton JM: Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk. Br J Cancer 102:799-802, 2010
9. Rennert G, Pinchev M, Rennert HS: Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol 28:3577-3581, 2010
10. Monsees GM, Malone KE, Tang MT, et al: Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 103:1752-1760, 2011
11. Rennert G, Pinchev M, Rennert HS, et al: Use of bisphosphonates and reduced risk of colorectal cancer. J Clin Oncol 29:1146-1150, 2011
12. Wolf AM, Hunter DJ, Colditz GA, et al: Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 23:991-999, 1994 (Pubitemid 24331214)
13. Feskanich D, Rimm EB, Giovannucci EL, et al: Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 93:790-796, 1993 (Pubitemid 23260170)
14. Rimm EB, Giovannucci EL, Stampfer MJ, et al: Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135:1114-1126, 1992
15. Rich-Edwards JW, Corsano KA, Stampfer MJ: Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 140:1016-1019, 1994 (Pubitemid 24373006)
16. Willett W, Stampfer MJ, Bain C, et al: Cigarette smoking, relative weight, and menopause. Am J Epidemiol 117:651-658, 1983 (Pubitemid 13100716)
17. Hu FB, Stampfer MJ, Rimm E, et al: Dietary fat and coronary heart disease: A comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531-540, 1999 (Pubitemid 29130020)
18. Bardou M, Barkun A, Martel M: Effect of statin therapy on colorectal cancer. Gut 59:1572-1585, 2010
19. Bonovas S, Filioussi K, Flordellis CS, et al: Statins and the risk of colorectal cancer: A metaanalysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 25:3462-3468, 2007 (Pubitemid 47310884)
20. Hoffmeister M, Chang-Claude J, Brenner H: Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: A population-based case-control study. Int J Cancer 121:1325-1330, 2007 (Pubitemid 47293801)
21. Poynter JN, Gruber SB, Higgins PD, et al: Statins and the risk of colorectal cancer. N Engl J Med 352:2184-2192, 2005 (Pubitemid 40727085)
22. Robertson DJ, Riis AH, Friis S, et al: Neither long-term statin use nor atherosclerotic disease is associated with risk of colorectal cancer. Clin Gastroenterol Hepatol 8:1056-1061, 2010
23. Singh H, Nugent Z, Demers A, et al: Exposure to bisphosphonates and risk of colorectal cancer: A population-based nested case-control study. Cancer 118:1236-1243, 2012